Yes, lidocaine can be safely applied internally to the rectum
Intrarectal lidocaine application is well-established, safe, and effective for various anorectal conditions and procedures. The FDA-approved lidocaine viscous solution specifically permits use in the mouth and throat, and while not explicitly labeled for rectal use, extensive clinical evidence demonstrates safety and efficacy for intrarectal application 1.
Evidence for Safety and Efficacy
Systemic Absorption and Safety Profile
Multiple pharmacokinetic studies confirm that intrarectal lidocaine achieves only minimal systemic absorption, well below toxic thresholds:
Single and repeated dosing studies: A 5% lidocaine ointment (125 mg dose) applied anorectally three times daily for 4 days produced peak plasma concentrations of only 145.9 ng/mL—more than 30-fold below the toxic threshold of 5,000-6,000 ng/mL 2. Even after multiple doses, accumulation was minimal (only 20-27% increase) 2.
Post-surgical application: Following hemorrhoidectomy, a combination ointment with 1.5% lidocaine showed maximum serum concentrations of only 73.6 ng/mL (median), with only 3 of 24 patients exceeding 1,000 ng/mL—still 4-5 times below CNS toxicity thresholds 3.
No adverse events: Across multiple studies, no serious local or systemic adverse events, arrhythmias, or significant ECG changes occurred with intrarectal lidocaine 2, 3, 4.
Clinical Applications
Intrarectal lidocaine has proven effective for:
Anorectal pain conditions: Hemorrhoids, anal fissures, fistulas, and proctitis respond well to 5% lidocaine ointment applied 2-3 times daily 2
Procedural anesthesia: 10 mL of 2% intrarectal lidocaine gel applied 10 minutes before transrectal prostate biopsy significantly reduced pain scores from 5 to 2 on a 10-point scale (p<0.00001) 4
Chronic visceral pain: 300 mg intrarectal lidocaine jelly significantly decreased abdominal pain in diarrhea-predominant IBS for at least 4 hours without side effects 5
Autonomic dysreflexia prevention: In spinal cord injury patients, 2% and 10% rectal lidocaine reduced autonomic dysreflexia severity by 32% and 50% respectively during bowel care 6
Practical Application Guidelines
Dosing Recommendations
- Standard anorectal pain: 2.5 g of 5% lidocaine ointment (125 mg) applied internally up to 3 times daily 2
- Procedural anesthesia: 10 mL of 2% lidocaine gel (200 mg) applied 10 minutes before procedure 4
- Chronic visceral pain: 300 mg lidocaine jelly as needed 5
Site-Specific Considerations
The location of rectal application affects first-pass hepatic metabolism: administration close to the anus (lower rectum) results in higher systemic bioavailability and less hepatic metabolism compared to administration 15 cm from the anus (upper rectum) 7. For local anesthetic effect, this distinction is less critical, but for minimizing systemic absorption, mid-to-upper rectal application may be preferable.
Important Caveats
Contraindications and precautions (per FDA labeling 1):
- Reduce doses in debilitated, elderly, or acutely ill patients
- Use caution in severe shock or heart block
- Avoid in patients with severe liver disease (though not an absolute contraindication in your scenario)
- True lidocaine allergy is rare (only 1% of adverse reactions) 8
Monitoring considerations:
- Plasma concentrations above 6 mcg/mL (6,000 ng/mL) correlate with increasing CNS toxicity symptoms 9
- Early toxicity signs include circumoral numbness, metallic taste, tinnitus, and dizziness 8
- With recommended anorectal doses, plasma levels remain 10-40 times below toxic thresholds 2, 3
Bottom Line
Intrarectal lidocaine application is both safe and effective when used at appropriate doses. The extensive pharmacokinetic data demonstrates negligible systemic absorption with standard dosing regimens, and clinical studies across multiple indications show consistent efficacy without significant adverse events. For your patient without contraindications, intrarectal lidocaine can be confidently recommended.